0001140361-13-044991.txt : 20131205 0001140361-13-044991.hdr.sgml : 20131205 20131205100538 ACCESSION NUMBER: 0001140361-13-044991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131203 FILED AS OF DATE: 20131205 DATE AS OF CHANGE: 20131205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYBERONICS INC CENTRAL INDEX KEY: 0000864683 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 760236465 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 100 CYBERONICS BLVD CITY: HOUSTON STATE: TX ZIP: 77058 BUSINESS PHONE: (281) 228-7200 MAIL ADDRESS: STREET 1: 100 CYBERONICS BLVD CITY: HOUSTON STATE: TX ZIP: 77058 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Verratti Mark CENTRAL INDEX KEY: 0001517026 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19806 FILM NUMBER: 131258968 MAIL ADDRESS: STREET 1: 100 CYBERONICS BLVD CITY: HOUSTON STATE: TX ZIP: 77058 4 1 doc1.xml FORM 4 X0306 4 2013-12-03 0 0000864683 CYBERONICS INC CYBX 0001517026 Verratti Mark 100 CYBERONICS BLVD HOUSTON TX 77058 0 1 0 0 VP Global Sales Common Stock 2013-12-03 4 M 0 18750 37.90 A 71469 D Common Stock 2013-12-03 4 S 0 18750 71.1188 D 52719 D Option to purchase common stock 37.90 2013-12-03 4 M 0 18750 0.00 A 2015-03-07 Common Stock 18750 49423 D Represents weighted average selling price. Securities were sold through approximately 72 separate sales on the transaction date at prices ranging from $70.87 to $71.70. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer, the full information regarding the number of shares and prices at which the transaction was effected. Reporting Person was granted an option to purchase 50,000 shares of common stock on March 7, 2005. The option is fully vested and expires March 7, 2015. The option was subject to certain vesting and forfeiture requirements in accordance with the terms of the applicable Stock Option Agreement. Mark S. Verratti 2013-12-05